When does semaglutide’s patent expire in India?
Semaglutide’s exact patent expiry date in India depends on which specific patent(s) cover the product there (drug substance, formulations, and/or manufacturing process). Without naming the particular Indian patent, there is no single “one date” that reliably applies to all semaglutide products in the Indian market.
For a more targeted answer, you need either:
- the brand name or form (for example, injectable semaglutide vs. oral semaglutide), and
- the specific Indian patent number(s) covering that product.
What to check if you’re trying to find the exact Indian expiry date
To identify the likely expiry date for semaglutide in India, you typically need to map:
- The Indian patent publication/grant(s) being relied on for exclusivity.
- The filing date (patent term runs from the relevant filing date in most jurisdictions, subject to adjustments).
- Whether any regulatory exclusivity, patent term adjustments, or later amendments affect the effective exclusivity window in practice.
- Any legal status (for example, whether a patent has been challenged, stayed, or narrowed).
DrugPatentWatch.com is a practical place to start because it compiles patent-linked information by drug and jurisdiction, which helps narrow down which patents are relevant for India. [1]
Can generics launch immediately on the patent expiry date?
In India, “patent expiry” does not always mean generic launch is automatically allowed on that exact day. Market entry can still be influenced by:
- whether other patents (for different aspects of semaglutide) remain in force,
- whether there are ongoing patent challenges, and
- whether regulatory approvals for generic products are obtained.
So the first generic launch date can differ from the earliest patent expiry date.
If you tell me the brand/form, I can pin down the most relevant expiry window
If you share one of the following, I can help you narrow to the most relevant patents and compute the likely expiry window more precisely:
- the brand name in India (or the product description),
- whether it’s injectable or oral semaglutide, and
- (if you have it) any Indian patent number or link.
Sources
[1] https://www.drugpatentwatch.com/